Vimarsana.com

Latest Breaking News On - Samarth kulkarni - Page 1 : vimarsana.com

Manchester Capital Management LLC Invests $63,000 in CRISPR Therapeutics AG (NASDAQ:CRSP)

Manchester Capital Management LLC purchased a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,000 shares of the company’s stock, valued at approximately $63,000. Several other hedge funds and other institutional investors have also […]

California
United-states
Canada
Manchester
United-kingdom
Raju-prasad
Samarth-kulkarni
Barclays
Brown-advisory-inc
Legacy-capital-group-california-inc
Securities-exchange-commission
Citigroup

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.9%

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 0.9% during mid-day trading on Monday . The company traded as low as $55.25 and last traded at $55.74. 217,015 shares changed hands during trading, a decline of 87% from the average session volume of 1,733,235 shares. The stock had previously closed at $56.22. […]

Canada
Samarth-kulkarni
Jamesr-kasinger
Investment-management
Capital-international-investors
Morgan-stanley
Needham-company
Royal-bank
Norges-bank
Avoro-capital-advisors
Therapeutics-company-profile
Securities-exchange-commission

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 0.9%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price was down 0.9% on Monday . The company traded as low as $55.25 and last traded at $55.74. Approximately 217,015 shares traded hands during trading, a decline of 87% from the average daily volume of 1,733,235 shares. The stock had previously closed at $56.22. Analyst […]

California
United-states
Robertw-baird
Samarth-kulkarni
Jamesr-kasinger
Cantor-fitzgerald
Barclays
Therapeutics-company-profile
Wolfe-research
Avoro-capital-advisors
Capital-international-sarl
Get-free-report

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 2.7%

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price was down 2.7% during trading on Thursday . The company traded as low as $55.34 and last traded at $55.43. Approximately 309,479 shares traded hands during trading, a decline of 82% from the average daily volume of 1,748,323 shares. The stock had previously closed at […]

Texas
United-states
California
Samarth-kulkarni
Jamesr-kasinger
Congress-asset-management-co
Morgan-stanley
Raymond-james-financial-services-advisors-inc
Capital-investment-advisory-services
California-public-employees-retirement-system
Cantor-fitzgerald
Citigroup

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.3%

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.3%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Canada
California
United-states
Jamesr-kasinger
Samarth-kulkarni
Avoro-capital-advisors
Securities-exchange-commission
Royal-bank
Wolfe-research
Barclays
Capital-international-ltd
Wells-fargo-company

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.7%

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.7%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Chad
Samarth-kulkarni
Raju-prasad
Wolfe-research
Jump-financial
Morgan-stanley
Royal-bank
Investment-management
Barclays
Wells-fargo-company
Invesco-ltd

Q2 2024 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Cut by Analyst

Q2 2024 EPS Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP) Cut by Analyst
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Canada
Samarth-kulkarni
Raju-prasad
Investment-management
Morgan-stanley
Citigroup
Charles-schwab-investment-management-inc
Capital-international-investors
Nasdaq
Vanguard-group-inc
Royal-bank
Therapeutics-company-profile

Leerink Partnrs Weighs in on CRISPR Therapeutics AG's Q2 2024 Earnings (NASDAQ:CRSP)

Leerink Partnrs Weighs in on CRISPR Therapeutics AG's Q2 2024 Earnings (NASDAQ:CRSP)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Samarth-kulkarni
Leerink-partnrs
Raju-prasad
Capital-international-ltd
Securities-exchange-commission
Therapeutics-company-profile
Royal-bank
Needham-company
Capital-international-inc
Capital-group-investment-management
Morgan-stanley

Research Analysts Set Expectations for CRISPR Therapeutics AG's Q2 2024 Earnings (NASDAQ:CRSP)

Research Analysts Set Expectations for CRISPR Therapeutics AG's Q2 2024 Earnings (NASDAQ:CRSP)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
Jamesr-kasinger
Samarth-kulkarni
Wells-fargo-company
Citigroup
Riggs-asset-managment-co
Securities-exchange-commission
Orion-capital-management
Royal-bank
Therapeutics-company-profile
Itau-unibanco-holding
Nasdaq

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 11.3%

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 11.3%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
Raju-prasad
Samarth-kulkarni
Needham-company
Bourgeon-capital-management
Therapeutics-company-profile
Securities-exchange-commission
Royal-bank
Principal-securities-inc
Riggs-asset-managment-co
Wells-fargo-company
Headlands-technologies

vimarsana © 2020. All Rights Reserved.